Retirement Planning Company of New England’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $344K | Buy |
849
+100
| +13% | +$40.5K | 0.15% | 166 |
|
|
2025
Q1 | $373K | Buy |
749
+13
| +2% | +$6.48K | 0.19% | 145 |
|
|
2024
Q4 | $383K | Buy |
736
+14
| +2% | +$7.29K | 0.19% | 139 |
|
|
2024
Q3 | $447K | Sell |
722
-16
| -2% | -$9.9K | 0.22% | 129 |
|
|
2024
Q2 | $408K | Sell |
738
-42
| -5% | -$23.2K | 0.22% | 129 |
|
|
2024
Q1 | $453K | Sell |
780
-4
| -0.5% | -$2.33K | 0.25% | 118 |
|
|
2023
Q4 | $416K | Buy |
784
+251
| +47% | +$133K | 0.19% | 132 |
|
|
2023
Q3 | $270K | Sell |
533
-101
| -16% | -$51.2K | 0.15% | 145 |
|
|
2023
Q2 | $331K | Buy |
634
+24
| +4% | +$12.5K | 0.19% | 142 |
|
|
2023
Q1 | $351K | Buy |
610
+13
| +2% | +$7.49K | 0.21% | 137 |
|
|
2022
Q4 | $329K | Sell |
597
-12
| -2% | -$6.61K | 0.21% | 137 |
|
|
2022
Q3 | $308K | Sell |
609
-1
| -0.2% | -$506 | 0.22% | 140 |
|
|
2022
Q2 | $331K | Buy |
610
+23
| +4% | +$12.5K | 0.23% | 132 |
|
|
2022
Q1 | $347K | Buy |
587
+261
| +80% | +$154K | 0.2% | 145 |
|
|
2021
Q4 | $217K | Buy |
+326
| New | +$217K | 0.11% | 206 |
|